How ACE inhibitors transformed the renin-angiotensin system.

British Journal of Pharmacology
Y S Bakhle

Abstract

The renin-angiotensin system (RAS) now underlies the successful treatment of almost 50% of the patients in cardiovascular medicine, with serious possibilities of extension to diabetes, Alzheimer's disease and cancer. This clinical transformation started just over 50 years ago, with the unexpected identification of a bradykinin-potentiating peptide from snake venom, as a potent inhibitor of ACE which led to the development of the first synthetic inhibitor, captopril, followed by the angiotensin receptor blockers. This article analyses the transformation of the RAS into its different stages, from academic experiments to clinical use and back to the laboratory, identifying the critical events involved, both clinical and scientific. The analysis also assesses the contributions of chance, coincidence, and conviction that were crucial in this transformation. Although questions remain, the transformation of the RAS over the past five decades provides a success story for medicine, for pharmacology, and, most significantly, for patients.

References

Mar 27, 1975·The New England Journal of Medicine·D H StreetenT G Dalakos
Nov 25, 1967·Nature·K K Ng, J R Vane
Apr 13, 1968·Nature·K K Ng, J R Vane
Jun 23, 1970·Biochemistry·S H FerreiraL J Greene
Jul 2, 1971·Science·D GantenJ Genest
Jul 1, 1971·Biochemical Pharmacology·D W Cushman, H S Cheung
Feb 1, 1969·British Journal of Pharmacology·J R Vane
May 22, 1973·Biochemistry·L D Byers, R Wolfenden
Jun 1, 1967·British Journal of Pharmacology and Chemotherapy·S H Ferreira, J R Vane
Jan 14, 1999·Journal of Hypertension·J ZhuoF A Mendelsohn
Oct 13, 2000·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·H J Manley
Apr 5, 2003·The International Journal of Biochemistry & Cell Biology·M J McKinleyS Y Chai
May 2, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Charles G Smith, John R Vane
Mar 1, 1956·The Journal of Experimental Medicine·L T SKEGGSN P SHUMWAY
Apr 1, 1961·Physiological Reviews·I H PAGE, F M BUMPUS
Oct 1, 1964·British Journal of Pharmacology and Chemotherapy·J R VANE
Feb 1, 1965·Transactions of the New York Academy of Sciences·F M BUMPUS
Feb 1, 1965·British Journal of Pharmacology and Chemotherapy·S H FERREIRA
Jan 19, 2005·Circulation·Duncan J CampbellMurray D Esler
Jul 2, 2010·British Journal of Pharmacology·Terry K W MaYat-Yin Lam
Oct 23, 2010·Nature Reviews. Cancer·Amee J GeorgeRoss D Hannan
Nov 30, 2013·Cardiology Clinics·Gabriel Sayer, Geetha Bhat
Jan 7, 2014·Current Opinion in Nephrology and Hypertension·Daniel C VillelaRobson A S Santos
Oct 17, 2014·Cardiovascular Therapeutics·Fujie ZhaoDao Wen Wang
Feb 11, 2015·The Lancet. Diabetes & Endocrinology·Bin WangYan-Gang Wang
Mar 16, 2016·Circulation·Scott A Hubers, Nancy J Brown
Jun 5, 2016·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Stefano Taddei, L Bortolotto
Aug 5, 2016·Journal of the Renin-angiotensin-aldosterone System : JRAAS·Frederik PerssonHans-Henrik Parving

❮ Previous
Next ❯

Citations

Jan 7, 2021·American Journal of Physiology. Lung Cellular and Molecular Physiology·Zaid AbassiSamuel N Heyman
Oct 30, 2020·Journal of Natural Products·Bernhard RetzlChristian W Gruber

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.